Search
for

    Research 10 of 1000+

    1. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial Journal of The European Academy of Dermatology and Venereology · 2021 · 11 citations
    2. Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial Annals of Dermatology · 2025
    3. The Role of Topical Finasteride in Hair Loss Management: Current Evidence and Future Perspectives International Journal of Biomedicine · 2023
    4. A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss. PubMed · 2016 · 1 citations
    5. Racial and Ethnic Disparities in Androgenetic Alopecia Clinical Trials in the United States Journal of dermatology and skin science · 2022
    6. 42173 Racial and ethnic disparities in androgenetic alopecia clinical trials in the USA Journal of The American Academy of Dermatology · 2023
    7. Effects of Dehydroepiandrosterone Therapy on Pubic Hair Growth and Psychological Well-Being in Adolescent Girls and Young Women with Central Adrenal Insufficiency: A Double-Blind, Randomized, Placebo-Controlled Phase III Trial The Journal of Clinical Endocrinology & Metabolism · 2009 · 49 citations
    8. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia Journal of Nutrition Health & Aging · 2013 · 211 citations
    9. Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial Journal of The European Academy of Dermatology and Venereology · 2021 · 5 citations
    10. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome European journal of cancer · 2016 · 294 citations
    All research results →

    Learn 1 of 27

    1. Finasteride Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically
    All learn results →

    Community

    — no results

    Try a deeper search in community →